Jw Asset Management, LLC Novo Nordisk A S Transaction History

Jw Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$102.11 - $135.92 $5.11 Million - $6.8 Million	-50,000 Reduced 42.3%	68,200 $8.76 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $5.37 Million - $11.8 Million	59,100 Added 100.0%	118,200 $10.7 Million
Q1 2023 May 05, 2023	BUY	$132.34 - $159.14 $1.93 Million - $2.32 Million	14,600 Added 32.81%	59,100 $9.41 Million
Q4 2022 Feb 10, 2023	BUY	$102.55 - $135.33 $4.56 Million - $6.02 Million	44,500 New	44,500 $6.02 Million

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Jw Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Jw Asset Management, LLC with notifications on news.